← SynDRA
TADALAFIL
SynDRA canonical compound SYN0001798 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | PDE5A |
| Mechanism of action | Phosphodiesterase inhibitor |
| Indication | erectile dysfunction |
| Disease area | urology |
All known targets
- PDE5A
- PDE11A
- Ache
- KCNH2
- NR2E1
- PDE6A
- PDE6B
- PDE6C
- PDE6D
- PDE6G
- PDE6H
- Pde5a
Mechanisms of action (all sources)
- Phosphodiesterase inhibitor
- PDE5A INHIBITOR
- Phosphodiesterase 5A inhibitor
Drug classes
- Phosphodiesterase 5 Inhibitors
- Cardiovascular Agents
- Enzyme Inhibitors
- Phosphodiesterase Inhibitors
- Urological Agents
- Vasodilator Agents
- Phosphodiesterase 5 Inhibitor
ATC classes
- G04B · UROLOGICALS
- OTHER ANTIHYPERTENSIVES
- DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Cross-references
Synonyms
- zalutia
- tardenafil
- tildenafil
- cialis
- IC351
- Tadalafilo
- Chewtadzy
- Tadalafil mylan
- Trans-tadalafil
- IC-351
- LY-450190
- LY450190
- NSC-750236
- NSC-759172
- Adcirca
- Adcirca (previously tadalafil lilly)
- Cialis
- Tadalafil component of entadfi
- Tadalafil component of opsynvi
- Tadalafil lilly
- Tadliq
- Talmanco (previously tadalafil generics)
- ADCIRCA
- Acdirca
- Tadanafil
- Lilly brand of tadalafil
- Tadalafil [USAN]
- GF-196960
- ICOS 351
- Ic351
- Cialis (TN)
- KS-1117
- Tadalafil (JAN/USAN/INN)
- Cialis, GF 196960, IC 351, ICOS 351, Tadalafil
- (6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
- (6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
- (6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
- CHEWTADZY
Reported adverse events
- Dyspepsia
- Priapism
- Headache
- Myalgia
- Flushing
- Back pain
- Hypertension
- Abdominal pain
- Nasopharyngitis
- Pain in extremity
- Dizziness
- Nasal congestion
Look up TADALAFIL in the interactive SynDRA portal →